ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GA20231-1mg |
|
77909-99-0 |
(Leu⁸,D-Trp²²,Tyr²⁵)-Somatostatin-28
|
0 | C138H209N41O40S2 | |
GA20231-005mg |
|
77909-99-0 |
(Leu⁸,D-Trp²²,Tyr²⁵)-Somatostatin-28
|
0 | C138H209N41O40S2 | |
GA20230-1mg |
|
179986-95-9 |
(Leu³¹,Pro³⁴)-Peptide YY (human)
|
0 | C195H296N54O56 | |
GA20230-005mg |
|
179986-95-9 |
(Leu³¹,Pro³⁴)-Peptide YY (human)
|
0 | C195H296N54O56 | |
GA20229-1mg |
|
132699-73-1 |
(Leu³¹,Pro³⁴)-Neuropeptide Y (human, rat)
|
0 | C189H284N54O56S | |
GA20229-005mg |
|
132699-73-1 |
(Leu³¹,Pro³⁴)-Neuropeptide Y (human, rat)
|
0 | C189H284N54O56S | |
GA20228-5mg |
|
39024-57-2 |
(Leu¹⁵)-Gastrin I (human)
|
0 | C98H126N20O31 | |
GA20228-1mg |
|
39024-57-2 |
(Leu¹⁵)-Gastrin I (human)
|
0 | C98H126N20O31 | |
GA20227-25mg |
|
362-39-0 |
(Ile⁸)-Oxytocin
|
0 | C43H66N12O12S2 | |
GA20227-5mg |
|
362-39-0 |
(Ile⁸)-Oxytocin
|
0 | C43H66N12O12S2 | |
GA20226-5mg |
|
163045-82-7 |
(Ile⁷⁶)-TNF-α (70-80) (human)
|
0 | C55H91N15O16 | |
GA20226-1mg |
|
163045-82-7 |
(Ile⁷⁶)-TNF-α (70-80) (human)
|
0 | C55H91N15O16 | |
GA20225-1mg |
|
181057-31-8 |
(Ile⁵,Trp²³,Tyr³⁶)-pTH-Related Protein (1-36) (human, mouse, rat)
|
0 | C196H308N58O53 | |
GA20225-005mg |
|
181057-31-8 |
(Ile⁵,Trp²³,Tyr³⁶)-pTH-Related Protein (1-36) (human, mouse, rat)
|
0 | C196H308N58O53 | |
GA20224-25mg |
|
34330-23-9 |
(Ile³)-Pressinoic acid
|
0 | C30H44N8O10S2 | |
GA20224-5mg |
|
34330-23-9 |
(Ile³)-Pressinoic acid
|
0 | C30H44N8O10S2 | |
GA20223-5mg |
|
393827-70-8 |
(Hyp⁴⁷⁴·⁴⁷⁷,Gln⁴⁷⁹)-cyclo-α-Fetoprotein (471-479) (human, lowland gorilla)
|
0 | C40H63N11O16S | |
GA20223-1mg |
|
393827-70-8 |
(Hyp⁴⁷⁴·⁴⁷⁷,Gln⁴⁷⁹)-cyclo-α-Fetoprotein (471-479) (human, lowland gorilla)
|
0 | C40H63N11O16S | |
GA20222-5mg |
|
159768-75-9 |
(Hyp³,β-(2-thienyl)-Ala⁵,Tyr(Me)⁸-psi(CH₂NH)Arg⁹)-Bradykinin
|
0 | C49H75N15O12S | |
GA20222-1mg |
|
159768-75-9 |
(Hyp³,β-(2-thienyl)-Ala⁵,Tyr(Me)⁸-psi(CH₂NH)Arg⁹)-Bradykinin
|
0 | C49H75N15O12S | |